These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33827840)

  • 21. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.
    Bai JW; Boulet G; Halpern EM; Lovblom LE; Eldelekli D; Keenan HA; Brent M; Paul N; Bril V; Cherney DZ; Weisman A; Perkins BA
    Cardiovasc Diabetol; 2016 Jan; 15():14. PubMed ID: 26809442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease.
    Byrne P; Cullinan J; Murphy C; Smith SM
    BMJ Open; 2018 Feb; 8(2):e018524. PubMed ID: 29439070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in preventing new-onset cardiovascular events with statin therapy in seniors aged 75 years and over: A cohort study in the South Korean National Health Insurance Database.
    Kim K; Kwak A; Choi CU; Kim JH; Kim MG; Oh JM; Ji E
    Basic Clin Pharmacol Toxicol; 2019 Aug; 125(2):108-116. PubMed ID: 30924261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
    Pavlovic J; Greenland P; Deckers JW; Brugts JJ; Kavousi M; Dhana K; Ikram MA; Hofman A; Stricker BH; Franco OH; Leening MJ
    JAMA Cardiol; 2016 Sep; 1(6):708-13. PubMed ID: 27439175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.
    Kaplan DE; Serper MA; Mehta R; Fox R; John B; Aytaman A; Baytarian M; Hunt K; Albrecht J; Njei B; Taddei TH;
    Gastroenterology; 2019 May; 156(6):1693-1706.e12. PubMed ID: 30660733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of Intracranial Hemorrhage From Statin Use in Asians: A Nationwide Cohort Study.
    Chang CH; Lin CH; Caffrey JL; Lee YC; Liu YC; Lin JW; Lai MS
    Circulation; 2015 Jun; 131(23):2070-8. PubMed ID: 25858194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of Absence of Coronary Artery Calcium to Cardiovascular Disease Mortality Risk Among Individuals Meeting Criteria for Statin Therapy According to the 2018/2019 ACC/AHA Guidelines.
    Rajan T; Rozanski A; Cainzos-Achirica M; Grandhi GR; Dardari ZA; Al-Mallah MH; Blankstein R; Miedema MD; Shaw LJ; Rumberger JA; Budoff MJ; Blaha MJ; Berman D; Nasir K
    Am J Cardiol; 2020 Dec; 136():49-55. PubMed ID: 32941817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins for primary prevention in adults aged 75 years and older: A nationwide population-based case-control study.
    Jun JE; Cho IJ; Han K; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Atherosclerosis; 2019 Apr; 283():28-34. PubMed ID: 30772771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk.
    Kohli-Lynch CN; Bellows BK; Thanassoulis G; Zhang Y; Pletcher MJ; Vittinghoff E; Pencina MJ; Kazi D; Sniderman AD; Moran AE
    JAMA Cardiol; 2019 Oct; 4(10):969-977. PubMed ID: 31461121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between statin use and all-cause mortality in cancer survivors, based on the Korean health insurance service between 2002 and 2015.
    Kim J; Choi EA; Han YE; Lee JW; Kim YS; Kim Y; You HS; Hyun HJ; Kang HT
    Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):434-440. PubMed ID: 31831365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes.
    Elam MB; Ginsberg HN; Lovato LC; Corson M; Largay J; Leiter LA; Lopez C; O'Connor PJ; Sweeney ME; Weiss D; Friedewald WT; Buse JB; Gerstein HC; Probstfield J; Grimm R; Ismail-Beigi F; Goff DC; Fleg JL; Rosenberg Y; Byington RP;
    JAMA Cardiol; 2017 Apr; 2(4):370-380. PubMed ID: 28030716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment Gap in the National Health-screening Program in Korea: Claim-based Follow-up of Statin Use for Sustained Hypercholesterolemia.
    Ahn E; Shin DW; Yang HK; Yun JM; Chun SH; Suh B; Lee H; Son KY; Cho B
    J Korean Med Sci; 2015 Sep; 30(9):1266-72. PubMed ID: 26339166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.
    Joentausta RM; Rannikko A; Murtola TJ
    Prostate; 2019 May; 79(6):583-591. PubMed ID: 30652328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.
    Son JS; Choi S; Kim K; Kim SM; Choi D; Lee G; Jeong SM; Park SY; Kim YY; Yun JM; Park SM
    JAMA; 2018 Nov; 320(17):1783-1792. PubMed ID: 30398603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study.
    Kim NH; Han KH; Choi J; Lee J; Kim SG
    BMJ; 2019 Sep; 366():l5125. PubMed ID: 31562117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statin prescribing for people with severe mental illnesses: a staggered cohort study of 'real-world' impacts.
    Blackburn R; Osborn D; Walters K; Falcaro M; Nazareth I; Petersen I
    BMJ Open; 2017 Mar; 7(3):e013154. PubMed ID: 28270387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin adherence is lower in primary than secondary prevention: A national follow-up study of new users.
    Sigglekow F; Horsburgh S; Parkin L
    PLoS One; 2020; 15(11):e0242424. PubMed ID: 33211724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.